Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery

Expert Opinion on Therapeutic Targets
Sauveur-Michel MairaCarlos Garcia-Echeverria

Abstract

A substantial number of epidemiologic and experimental studies support an important role for Class I phosphatidylinositol 3-kinases (PI3Ks) in the biology of human cancer. This article reviews the authors' understanding of the role of Class IA PI3K in the biology of human cancers and present discovery efforts to identify and develop inhibitors of this class of lipid kinases. Books, journals, databases and websites have been searched to find the latest information on the subject. In spite of the progress made over the past few years, more studies are still needed to better understand the biology of this pathway, its interaction(s) with other signaling cascades, and the role of the individual paralogs and PI3Kalpha mutants in human cancer. From a drug discovery perspective, medicinal chemistry efforts have led to the discovery of new pan-PI3K and isoform selective inhibitors with improved specificity, potency and pharmaceutical properties. Phase I clinical studies have been initiated with some of these PI3K inhibitors and the efficacy and therapeutic index of this new generation of anticancer agents is eagerly awaited.

References

Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A SjölanderE G Lapetina
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D R KaplanL Cantley
Aug 18, 1994·Nature·P Rodriguez-VicianaJ Downward
Sep 6, 1996·The Journal of Biological Chemistry·A D KohnR A Roth
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B VanhaesebroeckM D Waterfield
Jul 1, 1997·Trends in Biochemical Sciences·B VanhaesebroeckM D Waterfield
Feb 12, 1998·The Journal of Biological Chemistry·M AndjelkovićB A Hemmings
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y E WhangC L Sawyers
Nov 7, 1998·The Journal of Biological Chemistry·J M KavranM A Lemmon
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D M Li, H Sun
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·X WuC L Sawyers
Nov 13, 1999·Nature Cell Biology·J Downward
Nov 13, 1999·Nature Cell Biology·S ChristoforidisM Zerial
Nov 24, 1999·Journal of the National Cancer Institute·I U AliM Dean
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jan 10, 2001·International Journal of Cancer. Journal International Du Cancer·H B SalvesenS Das

❮ Previous
Next ❯

Citations

Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Susan WeeChristoph Lengauer
Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MarkmanJ Baselga
May 23, 2008·Carcinogenesis·Victor E Velculescu
Apr 26, 2012·Molecular Cancer Therapeutics·Dharmalingam SubramaniamShrikant Anant
Apr 24, 2008·Breast Cancer Research : BCR·Michael Rugaard JensenPatrick Chène
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Todd W MillerCarlos L Arteaga
Apr 1, 2009·Future Medicinal Chemistry·Sauveur-Michel MairaFrédéric Stauffer
May 20, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Rafiqa EachkotiE PremKumar Reddy
Dec 1, 2008·Expert Opinion on Drug Discovery·Yong Jia
Mar 18, 2015·Molecular Medicine Reports·Ming-Na LiuBing-Rong Liu
Oct 17, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Meghna TalekarSanjay Garg
Feb 10, 2009·Current Opinion in Cell Biology·Saskia BrachmannCarlos García-Echeverría
Jun 27, 2009·Biotechnology Journal·Elodie CouplanJacques Delarue
Apr 11, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Qi Wu, Qiang Liu
Oct 31, 2009·International Journal of Cancer. Journal International Du Cancer·Nadine DannemannPeter K Vogt
May 31, 2016·Journal of Pharmaceutical Sciences·Po-Chang ChiangLaurent Salphati
Aug 27, 2016·ACS Medicinal Chemistry Letters·Klemens HoegenauerFrédéric Zécri
Sep 16, 2016·Journal of Drug Targeting·Azam Roohi, Mohammad Hojjat-Farsangi
Sep 17, 2008·Oncogene·C Garcia-Echeverria, W R Sellers
Mar 10, 2016·Oncotarget·Robin T VargheseZhi Sheng
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria C ManaraKatia Scotlandi
Feb 22, 2013·Molecular Cancer Therapeutics·Sivapriya PonnurangamDharmalingam Subramaniam
Jun 3, 2021·International Journal of Molecular Sciences·Adrian ZającJoanna Jakubowicz-Gil
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B MarkmanJ Baselga
May 5, 2016·Journal of Chemical Information and Modeling·Daniel RobinsonWoody Sherman
Apr 30, 2019·Journal of Medicinal Chemistry·Hong JiaScott D Bembenek

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.